Bionik Laboratories

Bionik Laboratories Gross Margin

The Gross Margin of Bionik Laboratories (BNKL) as of Nov 19, 2026 is 54.83 %. In the previous year, Gross Margin was 74.84 % — a change of -26.73% (lower).

Gross Margin

54.83 %

YoY

-26.73%

Last updated:

Gross Margin of Bionik Laboratories is 2023 54.83 % . Gross Margin of Bionik Laboratories was 2022 74.84 % . It decreases by -26.73% lower compared to the previous year.

Bionik Laboratories's gross margin stands at 54.8%, up from 49.8% several years earlier.

The Bionik Laboratories Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2015
-16.67 USD
Jan 1, 2017
32.03 USD
Jan 1, 2018
59.22 USD
Jan 1, 2019
49.78 USD
Jan 1, 2020
58.51 USD
Jan 1, 2021
77.41 USD
Jan 1, 2022
74.84 USD
Jan 1, 2023
54.83 USD
The Bionik Laboratories Gross Margin history
YEARGross MarginYoY
54.83 %-26.73%
74.84 %-3.31%
77.41 %+32.29%
58.51 %+17.54%
49.78 %-15.94%
59.22 %+84.90%
32.03 %-292.17%
-16.67 %-116.67%
100.00 %+9,900.00%
1.00 %0.00%
1.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bionik Laboratories Stock analysis

What does Bionik Laboratories do? Bionik Laboratories Corp. generates revenue through its portfolio of rehabilitation products designed for neurological and mobility-impaired patients. The company offers InMotion ARM, InMotion ARM/HAND, and InMotion Robots as fully developed clinical solutions, with InMotion CONNECT serving as a complementary platform. InMotion Home is in development as an at-home upper extremity therapy product. These products target healthcare providers and rehabilitation centers seeking advanced robotic therapies for stroke and mobility disorders. The company's focus on AI-driven rehabilitation solutions positions it to serve the growing market for smart, patient-centric mobility recovery systems. The business model relies on selling robotic therapy systems and software platforms to clinical facilities and home care settings. InMotion ARM and InMotion ARM/HAND are deployed in professional rehabilitation environments, while InMotion Home aims to expand access to therapy beyond clinical walls. InMotion CONNECT supports data-driven treatment planning and progress tracking, enhancing the value proposition for healthcare institutions. The company monetizes through product sales and potentially service contracts for its AI-enhanced rehabilitation systems. Bionik Laboratories Corp. targets healthcare providers specializing in neurological rehabilitation, including hospitals and outpatient clinics. Its products address upper and lower extremity rehabilitation needs, with a primary focus on stroke recovery. The company's development pipeline includes three market-ready products and three in various stages of development, ensuring a steady stream of revenue opportunities as products progress from development to commercialization. Bionik Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bionik Laboratories stock

Gross Margin of Bionik Laboratories is 54.83 % in 2023.

Gross Margin of Bionik Laboratories changed from 74.84 % to 54.83 %, representing a -26.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Bionik Laboratories since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bionik Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bionik Laboratories

All Key Metrics — Bionik Laboratories